Eric is the CEO and co-founder of Tempus, a technology company that built a system to help fight cancer. Apart from Tempus, he is the founding partner of Lightbank – a venture fund that invests in disruptive tech, Groupon – global e-commerce market and uptake technologies, which is the number one predictive analytics platform for the world’s largest companies. Others are MediaOcean, Echo Global Logistics, and InnerWorkings.Ten years ago – 2006, together with his wife Liz, Eric started the Lefkofsky Family Foundation. This charitable foundation helps advance high impact initiatives in the community. Eric also serves as a trustee of other institutions such as The Art Institute of Chicago. He is also a board member at Steppenwolf Theatre Company and an adjunct professor at the University of Chicago. Follow Eric on Twitter (@lefkofsky) and Facebook (@eplefkofsky) to know more about him.
ChicagoInno article recap
The article was about how Eric Lefkofsky’s Tempus used data to help fight breast cancer by giving University of Chicago doctor’s data. The startup announced the partnership on Thursday. It will provide analysis and molecular sequencing to UChicago’s breast cancer specialists to come up with effective treatment plans for cancer patients. Tempus will sample data from more than one thousand patients to help cancer specialists know patterns that can predict how patients react to treatment.
This data will lead to better treatment over time, which is the primary goal of the deal.According to Dr. OlufunmilayoOlopade, a professor, and dean at the University of Chicago, there is less accessible data on former breast cancer patients. This is despite it being a common type of cancer. He added that they were excited to collaborate with Tempus on the initiative.Tempus was founded in 2015, and it uses genomic sequencing and machine learning to help cancer specialists make effective treatment decisions. Its headquarters is 600 W. Chicago. UChicago is one of the latest strings of partners. They are working with Mayo Clinic, University of Michigan, Penn Medicine, Robert H. Lurie Cancer Center of Northwestern University, and Rush University Medical Center to use data to fight breast cancer.